Goldman Sachs’s TriSalus Life Sciences TLSI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.6K | Sell |
16,816
-17,084
| -50% | -$93.1K | ﹤0.01% | 4898 |
|
|
2025
Q1 | $187K | Buy |
+33,900
| New | +$187K | ﹤0.01% | 4695 |
|
|
2024
Q3 | – | Sell |
-23,045
| Closed | -$127K | – | 5005 |
|
|
2024
Q2 | $127K | Sell |
23,045
-31,430
| -58% | -$173K | ﹤0.01% | 4466 |
|
|
2024
Q1 | $531K | Buy |
+54,475
| New | +$531K | ﹤0.01% | 3965 |
|
|
2022
Q4 | – | Sell |
-135,789
| Closed | -$1.35M | – | 5354 |
|
|
2022
Q3 | $1.35M | Sell |
135,789
-305,570
| -69% | -$3.03M | ﹤0.01% | 3652 |
|
|
2022
Q2 | $4.35M | Buy |
441,359
+50,500
| +13% | +$497K | ﹤0.01% | 2768 |
|
|
2022
Q1 | $3.83M | Buy |
390,859
+255,279
| +188% | +$2.5M | ﹤0.01% | 3018 |
|
|
2021
Q4 | $1.34M | Hold |
135,580
| – | – | ﹤0.01% | 3805 |
|
|
2021
Q3 | $1.35M | Sell |
135,580
-37,100
| -21% | -$368K | ﹤0.01% | 3780 |
|
|
2021
Q2 | $1.68M | Buy |
172,680
+14,980
| +9% | +$145K | ﹤0.01% | 3647 |
|
|
2021
Q1 | $1.52M | Buy |
+157,700
| New | +$1.52M | ﹤0.01% | 3609 |
|